VitaNova Life Sciences (VNOV) Cash from Investing Activities (2017)
VitaNova Life Sciences' (VNOV) quarterly Cash from Investing Activities came in at -$16538.0 in Q4 2017.
Powered by 
Analysis
VitaNova Life Sciences (VNOV) Cash from Investing Activities (2017) Analysis & Trends
VitaNova Life Sciences has disclosed Cash from Investing Activities across 1 years of filings, most recently posting -$16538.0 for Q4 2017.
- Cash from Investing Activities for Q4 2017 came in at -$16538.0, changed N/A year-over-year; the trailing twelve-month figure through Jan 2020 was -$16538.0 (changed N/A YoY), and the FY2018 annual result was -$33914.0, changed N/A from the prior year.
- Cash from Investing Activities for Q4 2017 stood at -$16538.0.
- Across five years, Cash from Investing Activities topped out at -$16538.0 in Q4 2017 and bottomed at -$16538.0 in Q4 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 120.96 Bn | 111.91 Bn | 6.13 Bn | -1.21 Bn |
| 2 | UL Solutions | 12.94 Bn | 12.53 Bn | 417.00 Mn | 131.00 Mn |
| 3 | Gartner | 11.74 Bn | 10.25 Bn | 1.19 Bn | -19.92 Mn |
| 4 | Booz Allen Hamilton Holding | 9.28 Bn | 8.74 Bn | 1.46 Bn | -328.00 Mn |
| 5 | Tetra Tech | 9.14 Bn | 8.91 Bn | 243.21 Mn | -20.68 Mn |
| 6 | Genpact | 5.74 Bn | 5.22 Bn | 490.34 Mn | 331.22 Mn |
| 7 | Grand Canyon Education | 3.97 Bn | 3.69 Bn | 204.08 Mn | 41.55 Mn |
| 8 | Fti Consulting | 3.91 Bn | 3.74 Bn | 316.27 Mn | -53.37 Mn |
| 9 | Korn Ferry | 3.90 Bn | 3.09 Bn | 681.29 Mn | 9.46 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.90 Mn | 30,521.00 | - |